Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.160
+0.060 (5.45%)
At close: May 12, 2025, 4:00 PM
1.150
-0.010 (-0.86%)
After-hours: May 12, 2025, 6:05 PM EDT
Akoya Biosciences Market Cap
Akoya Biosciences has a market cap or net worth of $57.79 million as of May 12, 2025. Its market cap has decreased by -69.37% in one year.
Market Cap
57.79M
Enterprise Value
113.97M
1-Year Change
-69.37%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since the IPO on April 16, 2021, Akoya Biosciences's market cap has decreased from $713.79M to $57.79M, a decrease of -91.90%. That is a compound annual growth rate of -46.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 57.79M | -49.09% |
| Dec 31, 2024 | 113.50M | -52.61% |
| Dec 29, 2023 | 239.49M | -34.07% |
| Dec 30, 2022 | 363.24M | -36.24% |
| Dec 31, 2021 | 569.65M | -20.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |